A PCSK9 Inhibitor in a Tablet? Meet Enlicitide, the New Oral Cholesterol Drug
For years, there was an easy examination question: “What is the major disadvantage of PCSK9 inhibitors?” One obvious answer was: they are injectable. Not anymore. On July 17, 2026, the...
Read More → 